RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of RARE
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Ultragenyx Pharmaceutical Inc. stock downgraded to Sell Candidate
(Updated on Mar 28, 2024)

Sell candidate since Mar 28, 2024 PDF

The Ultragenyx Pharmaceutical Inc. stock price fell by -0.278% on the last day (Thursday, 28th Mar 2024) from $46.82 to $46.69. During the last trading day the stock fluctuated 1.82% from a day low at $46.28 to a day high of $47.12. The price has been going up and down for this period, and there has been a 0.09% gain for the last 2 weeks. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -87 thousand shares and in total, 434 thousand shares were bought and sold for approximately $20.26 million.

The stock lies in the lower part of a wide and weak rising trend in the short term, and this may normally pose a very good buying opportunity. If the lower trend floor at $44.83 is broken, it will firstly indicate a slower rate of rising, but may also be an early warning for a trend shift. Given the current short-term trend, the stock is expected to rise 5.63% during the next 3 months and, with a 90% probability hold a price between $47.36 and $57.67 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

RARE Signals & Forecast

A buy signal was issued from a pivot bottom point on Monday, March 25, 2024, and so far it has risen 2.80%. Further rise is indicated until a new top pivot has been found. Some negative signals were issued as well, and these may have some influence on the near short-term development. The Ultragenyx Pharmaceutical Inc. stock holds a buy signal from the short-term Moving Average; at the same time, however, the long-term average holds a general sell signal. Since the longterm average is above the short-term average there is a general sell signal in the stock giving a more negative forecast for the stock. On further gains, the stock will meet resistance from the long-term Moving Average at $48.40. On a fall, the stock will find some support from the short-term average at $46.27. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sell signal and strengthen the general signal. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell together with the price during the last trading day and this reduces the overall risk as volume should follow the price movements.

Buy
Special Signal Notification

Double Bottom Formation

Double Bottom Formation A buy signal from a double bottom formation was found on Friday, February 02, 2024 and based on theory for this formation the price should go up by 1.69% to $47.48 within 11 trading days since signal was issued (Monday, April 01, 2024).

Support, Risk & Stop-loss for Ultragenyx Pharmaceutical Inc. stock

Ultragenyx Pharmaceutical Inc. finds support from accumulated volume at $46.65 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.84 between high and low, or 1.82%. For the last week, the stock has had daily average volatility of 2.84%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (RARE) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect Ultragenyx Pharmaceutical Inc. to open at $46.70, and during the day (based on 14 day Average True Range), to move between $45.09 and $48.29, which gives a possible trading interval of +/-$1.60 (+/-3.43%) up or down from last closing price. If Ultragenyx Pharmaceutical Inc. takes out the full calculated possible swing range there will be an estimated 6.86% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $46.65 (0.09%) than the resistance at $47.09 (0.86%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Ultragenyx Pharmaceutical Inc. stock A Buy?

Ultragenyx Pharmaceutical Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

Current score: -1.941 Sell Candidate Downgraded

Predicted Opening Price for Ultragenyx Pharmaceutical Inc. of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$46.70 ( 0.0143%) $46.69

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for RARE

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 47.54 1.81 %
R2 47.22 1.13 %
R1 47.02 0.702 %
Current price: 46.69
Support S1 46.38 -0.673 %
S2 46.18 -1.10 %
S3 45.86 -1.78 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 49.78 6.62 %
R2 47.37 1.46 %
R1 47.09 0.86 %
Current price 46.69
Support S1 46.65 -0.0857%
S2 44.60 -4.48%
S3 44.00 -5.76%

FAQ

What is the symbol for Ultragenyx Pharmaceutical Inc. Stock and on which exchange is it traded?
The symbol for Ultragenyx Pharmaceutical Inc. is RARE and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ultragenyx Pharmaceutical Inc. Stock?
Ultragenyx Pharmaceutical Inc. holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We, therefore, hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Hold/Accumulate to a Sell candidate.

How to buy Ultragenyx Pharmaceutical Inc. Stock?
Ultragenyx Pharmaceutical Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ultragenyx Pharmaceutical Inc. Stock.

What's the current price of Ultragenyx Pharmaceutical Inc. Stock?
As of the end of day on the 2024-03-28, the price of an Ultragenyx Pharmaceutical Inc. (RARE) share was $46.69.

What is the 52-week high and low for Ultragenyx Pharmaceutical Inc. Stock?
The 52-week high for Ultragenyx Pharmaceutical Inc. Stock is $54.98 and the 52-week low is $31.52.

What is the market capitalization of Ultragenyx Pharmaceutical Inc. Stock?
As of the 2024-03-28, the market capitalization of Ultragenyx Pharmaceutical Inc. is 3.844B.

When is the next earnings date for Ultragenyx Pharmaceutical Inc.?
The upcoming earnings date for Ultragenyx Pharmaceutical Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About Ultragenyx Pharmaceutical Inc.

Ultragenyx Pharmaceutical. Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia... RARE Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT